Antimicrobial Susceptibility Testing Market

The antimicrobial susceptibility market is projected to reach USD 5.68 billion by 2029 from USD 4.45 billion in 2024, growing at a CAGR of 5.0% during the forecast period. Major driving factors for antimicrobial susceptibility market growth come from the increasing prevalence of antibiotic-resistant infections and greater demand for effective treatments. Resistance from bacteria and other pathogens is growing against currently used antibiotics, which further compels health systems towards finding new antimicrobial agents and their testing methods to overcome this new evolving threat. Awareness of AMR among healthcare providers and patients, increased use of better diagnostic technologies, has a pushing effect on the market. Governments and organizations are also investing in research and development in this field of AMR, accelerating the pace of innovation and growth in the market.

The antimicrobial susceptibility testing market is highly competitive with few players, continuous innovations, and technological advancements. Development of automated and high-throughput systems, integrated molecular and genomic technologies, and improvement in the accuracy and turnaround time of the tests are the key competitive factors. Moreover, the market players are investing in research and development to improve their products and sustain the competition in the AST market, hence keeping it lively and one of the rapidly growing sectors.. Here are some of the key players in the Antimicrobial susceptibility market: BioMérieux (France), Becton, Dickinson and company (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Bio-Rad laboratories (US), Bruker (US), Roche diagnostics (Switzerland, Accelerate diagnostics (US), Himedia laboratories (India), Liofilchem s.r.l.(Italy), Alifax s.r.l.(Italy), Creative Diagnostics (US), and others are of the prominent companies in the Antimicrobial susceptibility market.

To know about the assumptions considered for the study download the pdf brochure

Biomerieux SA (France): BioMérieux is one of the major players in the Antimicrobial Susceptibility Testing market and is widely recognized for its innovative solutions, continuously being enhanced for several decades to make microbial resistance detection faster and more accurate. The company's portfolio of AST systems includes automated solutions such as VITEK 2 and new VITEK MS, using enhanced technologies for speed and reliability of results. The bioMérieux portfolio has been developed in response to an increasing demand for more accurate and detailed antimicrobial susceptibility profiles that can help the clinician optimize appropriate therapies in the face of a growing challenge of resistant infections. Devotion to continuous research and development helps keep its AST solutions state-of-the-art as they address microbial resistance and improve patient outcomes worldwide.

Becton,dickinson and company (US): Becton, Dickinson and Company, commonly known as BD, is one of the major companies operating in the AST market by offering a suite of advanced solutions that will help increase diagnostic precision and speed. Indeed, innovative BD systems such as BD Phoenix and BD Bruker MALDI Biotyper combine sophisticated technology into a fast and precise susceptibility profile to assist health professionals in making the appropriate treatment decisions. These systems are designed to take on the more vexing problem of antimicrobial resistance by providing reliable results that guide appropriate antimicrobial therapy. BD is committed to advancing AST technology in support of their mission to improve patient care and combat the threat of resistant infections worldwide.

Thermo Fisher Scientific, Inc. (US): Thermo Fisher Scientific has become pivotal in the AST market with its broad diagnostics suite that can handle the challenges associated with microbial resistance. The company avails products such as the Thermo Scientific Sensititre and Thermo Scientific MAS systems, which are enabled with advanced technologies that deliver precise and fast susceptibility profiles. These systems are critical in the determination of efficient antimicrobial treatments and informing clinical decisions. Thermo Fisher's passion for innovation and high-quality diagnostics helps healthcare professionals stay one step ahead of emerging resistance trends, while continuing to improve patient outcomes and contributing to the global fight against antibiotic resistance.

Bio-rad laboratories (US):  Bio-rad offers innovative solutions that will help in the detection and management of resistance to antimicrobials. Product lines include the Bio-Rad MRSA-Screen and the Bio-Rad VITEK 2 Systems that offer accurate and reliable testing to guide appropriate treatment options. These technologies have been developed in such a way as to help facilitate the process of susceptibility testing for the laboratory to quickly pick out the resistant strains and thereby suggest therapies appropriately. Bio-Rad remains committed to the development of AST methodologies that can help health providers meet the challenges imposed by antimicrobial resistance, thus providing optimum care for the patients by delivering timely and accurate diagnostic information.

Danaher corporation (US): Danaher Corporation is one of the key players in the AST market, through the availing of sophisticated diagnostic technologies that address this challenge in the fight against antimicrobial resistance. Danaher has a portfolio composition that includes products from various subsidiaries, including Beckman Coulter and Cepheid. The company offers the DxN VERIS and the BECKMAN COULTER MicroScan systems. These two systems ensure fast, true, and complete AST results, thereby enabling timely and appropriate treatment decisions. With Danaher's emphasis on innovative and precise diagnostic testing, it leverages support for the current global effort necessary in addressing the rising problem of antimicrobial resistance, hence improving patient outcomes and overall efficiency in the delivery of healthcare.

Related Reports:

Antimicrobial Susceptibility Testing Market by Product (Manual (Disk, Strip, Plate), Automated, Molecular), Method (e-test, Disk & Agar Diffusion, Genotypic), Type (Antibacterial, Antifungal), Application (Clinical, Epidemiology) Global Forecasts to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]